Activation of the type I interferon (IFN) response is an essential defense mechanism against invading pathogens such as viruses. This chapter describes two protocols to quantify activation of the chicken IFN response through analysis of gene expression by real-time quantitative PCR and by quantification of bioactive IFN protein using a bioassay.
Introduction
The type I interferon response (IFN response) is an important part of the immune reaction against viruses. Interferon alpha and beta (IFNα and IFNβ) are the prototypical type I interferons and can be produced by most animal cells. Production of IFNα/β is triggered upon stimulation of pattern recognition receptors, such as Toll like receptors (TLRs) or Rig-I like receptors (RLRs). Upon production, IFNα and IFNβ are rapidly secreted to the extracellular compartment, where they can bind to the ubiquitously expressed IFN receptor. Binding of IFN to the receptor activates the JAK/STAT signaling pathway, leading to the formation of the ISGF3 transcription complex consisting of a STAT1, STAT2, and IRF9. In the nucleus, the ISGF3 complex induces transcription of hundreds of IFN-stimulated genes (ISGs) [1] . Many of these genes encode proteins that interfere with the replicative cycle of viruses at various stages (reviewed in ref. 2) . The IFN response is a potent antiviral mechanism, and therefore, most viruses have been evolutionarily selected to counteract it and coronaviruses are no exception (reviewed by Zhong et al. [3] ).
In this chapter we describe two protocols to quantify activation of the IFN response. We have found these protocols useful to study if and how viruses counteract the IFN response in chicken cells. The first protocol describes how to quantify activation of the IFN response at the transcriptional level using real-time quantitative PCR (RT-qPCR) on Ifn and IFN-stimulated genes. The second protocol describes quantification of bioactive type-I IFN protein (both IFNα and IFNβ) by the use of a reporter cell line. This bioassay can be used to quantify IFN secreted in response to virus infection and, when combined with transcription analysis of Ifnα and Ifnβ these assays can provide an integral picture of activation of the chicken IFN response.
Similar to most mammalian cell lines, activation of the interferon response in most chicken cells is characterized by upregulation of Ifnβ. Like the human genome, the chicken genome encodes only one copy of the Ifnβ gene, whereas at least ten isoforms of Ifnα are present [4, 5] . Similar to mammals, production of chicken IFNα is mainly mediated by monocytes; other cells mainly produce IFNβ in response to viral infection [6] . Because avian coronaviruses replicate mainly in epithelial cells, we monitor activation of the type I interferon response by quantification of Ifnβ. Similar to mammalian cells, Ifnβ is upregulated upon activation of either TLR or Rig-I like receptors (RLRs), but not in response to stimulation with IFN. Concomitant with Ifnβ, many ISGs are also upregulated, indicating that the term interferon stimulated genes is somewhat misleading [7] . Studying the expression of ISGs can be useful, therefore we have provided a list of avian-specific primers for use in real-time quantitative PCR (RT-qPCR; Table 1 ) [8] [9] [10] . Protocols for RNA isolation, cDNA synthesis and real-time PCR are plenty and every lab has its own protocols. In this chapter we describe briefly the methods used in our lab. For a detailed overview of RT-qPCR techniques and theoretical background, please refer to Forlenza et al. [11] .
The chicken interferon bioassay was developed in the laboratory of Prof. P. Staeheli [12] . It is based on a quail cell line (CEC-32) that contains the luciferase gene downstream of a part of the inducible chicken mx promoter. Stimulation of these cells with type I interferon readily induces activation of the mx promoter and subsequent production of the firefly luciferase enzyme. Firefly luciferase can be easily quantified using commercially available luciferase assay kits. Here we provide a step-by-step protocol for measuring IFN concentrations using this bioassay.
Materials
1. Cells and virus, as per experiment.
RNeasy Mini Kit (QIAgen).
3. RNase-free DNase set (QIAgen). 
Quantitation of Transcription of Chicken Ifn-Related Genes

Quantitation of Chicken Type I IFN Protein Using a Bioassay
RNA Isolation, cDNA Synthesis, and RT-qPCR on Avian Cells
With: R = fold change of the target gene relative to the control Calibrator = control cells at time point 0 (zero) E = average amplification efficiency for that set of primers C t = cycle threshold 1. If the samples contain virus, heat-inactivate at 56 °C for 30 min prior to performing the assay. This treatment inactivates coronaviruses but retains bioactivity of type I IFN (see Note 5).
2. Fill a sterile 96-well plate with 50 μl stimulation medium/well.
3. Add 50 μl chIFNα standard (50 U/ml) or test sample to the first row (vortex before adding).
4. Make serial twofold dilutions in the plate using a multichannel pipet (Fig. 1, see Note 6 ).
5.
Remove the medium from the CEC-32 cells which have been cultured in the 96-well plate (see Note 7). 6 . Transfer the content of the plate containing the diluted samples and standard to the CEC-32 cells (see Note 8).
Quantification of Chicken Type I IFN Protein Using a Bioassay
7. Incubate plates at 37 °C and 5 % CO 2 for 6 h.
8. Use a firefly luciferase assay kit to detect luciferase activity, according to manufacturer's instructions.
To calculate the units of interferon in the original sample, a workflow is provided in Fig. 2. 1. Transfer the measurements from the luminometer to a spreadsheet program (Microsoft Excel or equivalent).
2. Calculate the average value of the background luminescence and subtract this value from all wells (Fig. 2, point A) .
3. Calculate the average of the wells incubated with the diluted interferon standard and plot them in a scatter plot. This graph is the standard curve (B).
4. Make a new graph using only the data points that fall within the linear range of the standard curve, usually 1-12.5 or 1-6 U/ml.
5.
Plot a linear trend line through these data points and display the equation on the chart (C).
6. Next, all luminescence values that fall within the linear range of the standard curve are selected (here 2-12 U/ml).
7. Calculate the IFN concentration in each well using the equation from the standard curve (D).
8.
Multiply by the dilution factor to obtain the concentration of IFN in the undiluted samples (E).
9. Finally, calculate the average IFN concentration of the wells that fall within the linear range (usually two or three wells per sample). This value corresponds to the final concentration of type I interferon in the original sample (F). Fig. 1 Layout of a 96-well plate to accommodate ten samples and an interferon standard 6. To select the appropriate dilutions it is advisable to perform a pilot experiment. One can either make an extensive twofold serial dilution series (for example, 2-1,024 times dilution), or use tenfold pre-dilutions. In our hands IFN production by avian cells rarely exceeds 5,000 U/ml, and therefore, a maximum of 1,000 times pre-dilution should suffice.
Calculation of IFN Concentration from Luminescence Data
7. Medium is removed simply by emptying the 96-well plate in the waste and gently tapping it dry on a stack of tissues. Sterility is not an issue, the cells will only be incubated for another 6 h.
8. CEC-32 cells should not be allowed to dry out! Make sure you transfer the samples to the cells within minutes. Drying of the monolayer will decrease the luminescence and thereby negatively influence the assay. When transferring the diluted samples to 96-well plate with CEC-32 cells, start with the lowest concentration and work your way up the dilutions. In this way the same tips can be used for multiple dilutions. Do not forget to add medium to the negative controls.
